Literature DB >> 28579171

The NDR/LATS protein kinases in immunology and cancer biology.

Ahmad A D Sharif1, Alexander Hergovich2.   

Abstract

The NDR (nuclear Dbf2-related)/LATS (large tumour suppressor) family of kinases represents a subclass of the AGC (protein kinase A (PKA)/PKG/PKC-like) group of serine/threonine protein kinases. Members of the NDR/LATS family are vital components of conserved pathways controlling essential cellular processes, such as proliferation (cell cycle progression) and cell death. In particular, the central involvement of NDR/LATS as YAP/TAZ kinases in the Hippo tissue growth control pathway has gained much interest. In this review, we summarise the roles of mammalian NDR1/2 (aka STK38/STK38L) and LATS1/2 in immunity and cancer biology. We also discuss the activation mechanisms of NDR/LATS involving Ste20-like kinases and the MOB1 signal transducer, followed by an overview of NDR/LATS knockout mouse models. We further review the mutation and expression status of NDR/LATS in human cancers and their possible predictive and/or prognostic value in cancer treatment.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AGC kinases; Cancer; Immunology; Large tumour suppressor kinase; STK38; STK38L; Serine/threonine protein kinases; nuclear Dbf2-related kinase

Mesh:

Substances:

Year:  2017        PMID: 28579171     DOI: 10.1016/j.semcancer.2017.04.010

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  21 in total

1.  Not the comfy chair! Cancer drugs that act against multiple active sites.

Authors:  Laurence Booth; Andrew Poklepovic; Paul Dent
Journal:  Expert Opin Ther Targets       Date:  2019-11-14       Impact factor: 6.902

2.  LATS2 Inhibits Malignant Behaviors of Glioma Cells via Inactivating YAP.

Authors:  Yi Shi; Decheng Geng; Yu Zhang; Min Zhao; Yan Wang; Yang Jiang; Rutong Yu; Xiuping Zhou
Journal:  J Mol Neurosci       Date:  2019-02-15       Impact factor: 3.444

3.  Furry protein suppresses nuclear localization of yes-associated protein (YAP) by activating NDR kinase and binding to YAP.

Authors:  Kazuki Irie; Tomoaki Nagai; Kensaku Mizuno
Journal:  J Biol Chem       Date:  2020-01-29       Impact factor: 5.157

4.  NDR1 activates CD47 transcription by increasing protein stability and nuclear location of ASCL1 to enhance cancer stem cell properties and evasion of phagocytosis in small cell lung cancer.

Authors:  Ling-Ling Wang; Xiao-Yun Wan; Tao-Li Wang; Chun-Qi Liu; Fei-Meng Zheng
Journal:  Med Oncol       Date:  2022-10-12       Impact factor: 3.738

Review 5.  The STK38-XPO1 axis, a new actor in physiology and cancer.

Authors:  Alexandre Pj Martin; Vasily N Aushev; Gérard Zalcman; Jacques H Camonis
Journal:  Cell Mol Life Sci       Date:  2020-11-03       Impact factor: 9.261

6.  Downregulation of NDR1 contributes to metastasis of prostate cancer cells via activating epithelial-mesenchymal transition.

Authors:  Juntao Yue; Huimin Sun; Shijie Liu; Fei Yu; Shanshan Wang; Fuli Wang; Ruixiong Shen; Feng Zhu; Lei Zhang; Chen Shao
Journal:  Cancer Med       Date:  2018-05-07       Impact factor: 4.452

7.  Ndr kinases regulate retinal interneuron proliferation and homeostasis.

Authors:  Hélène Léger; Evelyn Santana; N Adrian Leu; Eliot T Smith; William A Beltran; Gustavo D Aguirre; Francis C Luca
Journal:  Sci Rep       Date:  2018-08-22       Impact factor: 4.379

Review 8.  MOB (Mps one Binder) Proteins in the Hippo Pathway and Cancer.

Authors:  Ramazan Gundogdu; Alexander Hergovich
Journal:  Cells       Date:  2019-06-10       Impact factor: 6.600

9.  The Hippo network kinase STK38 contributes to protein homeostasis by inhibiting BAG3-mediated autophagy.

Authors:  Christina Klimek; Ricarda Jahnke; Judith Wördehoff; Barbara Kathage; Daniela Stadel; Christian Behrends; Alexander Hergovich; Jörg Höhfeld
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2019-07-19       Impact factor: 4.739

Review 10.  The Roles of YAP/TAZ and the Hippo Pathway in Healthy and Diseased Skin.

Authors:  Emanuel Rognoni; Gernot Walko
Journal:  Cells       Date:  2019-05-03       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.